Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference39 articles.
1. Antonelli, G., Simeoni, E., Bagnato, F., Pozzilli, C., Turriziani, O., Tesoro, R., Di Marco, P., Gasperini, C., Fieschi, C., Dianzani, F., 1999. Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b. J. Neurol. Sci. 15;168(2): 131.
2. Interferon β neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations;Bertolotto;Immunopharmacology,2000
3. Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification;Bertolotto;J. Immunol. Methods,2001
4. Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory;Bertolotto;J. Neurol. Neurosurg. Psychiatry,2002
5. Persistent neutralizing antibodies abolish the interferonβ bioavailability in MS patients;Bertolotto;Neurology,2003
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study;Neurologia i Neurochirurgia Polska;2018-12-11
2. Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis;Journal of Clinical Neurology;2018
3. Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments;Neuroinflammation;2018
4. Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2017-10-09
5. Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents;Therapeutic Drug Monitoring;2017-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3